COVID-19 Vaccine Acceptance among an Online Sample of Sexual and Gender Minority Men and Transgender Women
- PMID: 33804530
- PMCID: PMC7999863
- DOI: 10.3390/vaccines9030204
COVID-19 Vaccine Acceptance among an Online Sample of Sexual and Gender Minority Men and Transgender Women
Abstract
Sexual and gender minority (SGM) populations are particularly vulnerable to poor COVID-19 outcomes and are more likely to experience stigma and medical mistrust that may impact COVID-19 vaccine acceptance. This study examined the prevalence of COVID testing and diagnosis and assessed COVID-19 vaccine acceptance among a large sample of SGM. Participants were recruited as part of an online cross-sectional study focused on an HIV biomedical prevention technology willingness in the United States at increased risk for HIV sero-conversion. Multivariate linear analysis was conducted to examine COVID-19 vaccine acceptance. The study sample included 1350 predominately gay (61.6%), Black (57.9%), cis-gender (95.7%) males with a mean age of 32.9 years. Medical mistrust and social concern regarding COVID-19 vaccine stigma were significantly associated with decreased COVID-19 vaccine acceptance, and altruism was significantly associated with increased vaccine acceptance. Black participants were significantly less likely to accept a COVID-19 vaccine, and Asian participants were significantly more likely to accept a vaccine, compared to White peers. As the planning of COVID-19 vaccine rollout efforts is conceptualized and designed, these data may inform equitable implementation strategies and prevent worsening health inequities among SGM populations.
Keywords: COVID-19; acceptance; gender; minority; sexual; vaccine.
Conflict of interest statement
The authors declare that there are no conflict of interest.
References
-
- McClung N., Chamberland M., Kinlaw K., Matthew D.B., Wallace M., Bell B.P., Lee G.M., Talbot H.K., Romero J.R., Oliver S.E., et al. The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine–United States, 2020. Morb. Mortal. Wkly. Rep. 2020;69:1782–1786. doi: 10.15585/mmwr.mm6947e3. - DOI - PMC - PubMed
-
- National Academies of Sciences A Framework for Equitable Allocation of Vaccine for the Novel Coronavirus. [(accessed on 27 February 2021)]; Available online: https://www.nationalacademies.org/our-work/a-framework-for.
Grants and funding
- P30 AI060354/AI/NIAID NIH HHS/United States
- U19 HD089881/HD/NICHD NIH HHS/United States
- U19HD089881/National Institutes of Health Adolescent Medicine Trials Network for HIV/AIDS Interventions and the University of North Carolina/Emory Center for Innovative Technology
- T32HS0226116/Agency for Healthcare Research and Quality
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
